Are you struggling to find CDMO capacity? Here are some of the drivers behind the contract manufacturing market's exponential growth.
- Single Use In Biopharma: Beyond Savings & Sustainability
- Unpacking The Importance Of Lipid Nanoparticle Production Platforms
- Cell Counting Is Growing More Important Amid Advanced Therapy’s Rise
- FDA Publishes Final Guidance On Reporting Listed Drug Amounts
- 2024 CIO Survey Reveals IT Budgets, AI Priorities For Life Sciences Companies
- AI And Pharmaceutical Development: WHO Calls For Ethical Framework, Good Governance
- Digitizing CMC Knowledge Management
EDITOR'S DESK
-
Doubling Down On Biopharma’s Growing Skills Drought
The biopharmaceutical industry is building manufacturing capacity at breakneck speed. According to PhRMA, there are 1,580-and-counting biopharma manufacturing facilities in the U.S. alone. Problem is, we're way short on filling those facilities with skilled labor. NIIMBL wants to change that. Here's how, and a great opportunity for big pharma, biotech sponsors, CDMOs, academics, and more to help.
The career of Debra Weiss, RN, MSN, and COO at the biopharma Gates Medical Research Institute (Gates MRI), offers a case study in creating success through service-oriented leadership.
Check out the results of DeciBio's Antibody-Drug Conjugates 2024 Industry Survey, which predict another bullish year for the growing modality.
The U.S. imported $6.95 billion worth of pharmaceuticals from China in 2022. That was 8x the amount we imported in 2021. A proposed Act of Congress puts that supply, and U.S. biotech itself, in serious peril.
In the U.K., a professor at the University of Birmingham is using virtual reality (VR) to help address the growing biomanufacturing skills shortage — using virtual reality (VR).
GUEST COLUMNISTS
-
Unpacking The Importance Of Lipid Nanoparticle Production Platforms
Batch processing platforms for LNPs lack efficiency, appropriate controls, and yield optimization. Continuous manufacturing platforms may address some of those issues.
-
Cell Counting Is Growing More Important Amid Advanced Therapy’s Rise
You can't improve what you don't measure. This discussion explores advances in cell counting technology and the growing number of ways it aids the biotech industry and beyond.
-
FDA Publishes Final Guidance On Reporting Listed Drug Amounts
Despite earlier efforts to shore up the U.S. drug supply chain, COVID-19 still brought shortages. A new FDA reporting system aims to reduce future supply risks.
-
2024 CIO Survey Reveals IT Budgets, AI Priorities For Life Sciences Companies
Clarkston Consulting conducted its third annual Chief Information Officer (CIO) Survey to understand IT budgets of life sciences companies, how AI priorities fit into those budgets, and more.
-
AI And Pharmaceutical Development: WHO Calls For Ethical Framework, Good Governance
The World Health Organization (WHO) recently released a document titled Benefits and risks of using artificial intelligence for pharmaceutical development and delivery describing the ethical issues and governance considerations for using AI in drug discovery, preclinical development, and clinical trials.
-
Digitizing CMC Knowledge Management
Systems that enhance know-how retention stretch from utterly simple to enterprise-scale. Here are some ideas for incorporating them into your knowledge management strategy.
-
Managing Supply Chain Risks Using Relational Risk Analysis
In the bio/pharma and medical device industries, you can easily model, understand, and manage supply chain risks using relational risk analysis. Here's how.
-
When Does GMP Matter In Non-GMP Settings?
Would you ever need to follow GMP standards in workspaces where GMP is not required or possible? This article digs into why, when, and how to follow the principles of GMP.
BIOPROCESSING WHITE PAPERS
-
3D Manufacturing Of Therapeutic hMSCs
Discover how our microcarrier-based technology harvests hMSCs while showing high proliferation capacity, expression of hMSC-specific markers, significant trilineage differentiation potential, and strong immunomodulatory and angiogenic potency.
-
Mycoplasma Contamination In Biopharmaceutical Manufacturing2/9/2024
Learn how following strict laboratory practices and conducting routine testing for Mycoplasma contamination using nucleic acid-based assays can help ensure the production of safe and high-quality biopharmaceutical products.
-
The Latest Trends In The Prevention And Treatment Of Cervical Cancer2/8/2024
Unearth what immune checkpoint inhibitors are showing promise in treating cervical cancer and how advancements in these treatments paired with additional prevention strategies are improving patient outcomes.
-
Review Of Annex 1 2022: Environmental Monitoring Changes9/13/2022
We highlight the changes to the new revision of the EU GMP Annex 1 regulatory standard for sterile drug products that was released in August 2022.
-
Downstream Processing In The Age Of Precision Medicine10/26/2022
Explore alternative processes and solutions being suggested to combat the bottleneck created by downstream processing that is seriously impacting the overall production of treatments and vaccines.
-
Strategies For Ensuring Biomanufacturing Resilience For Biologics6/29/2023
Long-term collaboration in resilient biomanufacturing capacity and supply chains ensures the reliable delivery of health technologies. Investigate biomanufacturing resilience strategies for biologics.
BIOPROCESSING APP NOTES & CASE STUDIES
- LCMS/MS Methodology For Mapping Disulfide Linkages In Etanercept
- Modeling And Online Estimation Of kLa And P/V
- Carryover Analysis Through Two Consecutive Cell Culture Harvests
- Electron Activated Dissociation Workflow For Biotherapeutics Characterization
- Secondary Packaging Strategies For Commercial Launch Of A Biologic
BIOPROCESS ONLINE CONTENT COLLECTIONS
This collection of articles, produced through a partnership between MilliporeSigma and Bioprocess Online, highlights the need for ongoing investment in resilient biomanufacturing capacity and supply chains to ensure the reliable delivery of health technologies like vaccines, even during crisis conditions.
More Content CollectionsFEATURED PRODUCTS AND SERVICES
ON-DEMAND WEBINARS
- Culturing And Characterizing Organoids And Cancer Spheroids
- How To Get Started With Organ-On-A-Chip Technology
- De-Risking The Aseptic Drug-Filling Process And Optimizing Production
- ChipChat With Emulate: Answering Your Organ-Chip Questions Live
- Assessing Reproductive Health With A Human Vagina-On-A-Chip
INDUSTRY NEWS
NEWSLETTER ARCHIVE
- 04.19.24 -- Developing & Implementing A Continuous Bioprocess Control Strategy
- 04.18.24 -- Bringing Therapies To Patients With Speed And Confidence
- 04.18.24 -- Process Mapping For More Effective Knowledge Management
- 04.17.24 -- Optimizing Drug Delivery Systems For Complex Biologics
- 04.17.24 -- Leverage Innovative Assays And Monitoring To Improve mAb Production